Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 7.5 USD -4.34%
Market Cap: 45.8m USD

Intrinsic Value

The intrinsic value of one ALGS stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.5 USD, Aligos Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALGS Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Aligos Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

ALGS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ALGS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
Compare ALGS to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALGS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aligos Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aligos Therapeutics Inc

Current Assets 143.2m
Cash & Short-Term Investments 137.9m
Other Current Assets 5.3m
Non-Current Assets 7.5m
PP&E 6.9m
Other Non-Current Assets 632k
Efficiency

Free Cash Flow Analysis
Aligos Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aligos Therapeutics Inc

Revenue
3.3m USD
Operating Expenses
-89.6m USD
Operating Income
-86.4m USD
Other Expenses
33.1m USD
Net Income
-53.3m USD
Fundamental Scores

ALGS Profitability Score
Profitability Due Diligence

Aligos Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Aligos Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ALGS Solvency Score
Solvency Due Diligence

Aligos Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Aligos Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

There are no price targets for ALGS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Aligos Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ALGS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ALGS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ALGS stock?

The intrinsic value of one ALGS stock under the Base Case scenario is hidden USD.

Is ALGS stock undervalued or overvalued?

Compared to the current market price of 7.5 USD, Aligos Therapeutics Inc is hidden .

Back to Top